Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[2002 Standards, Options and Recommendations: good practice for the management and shipment of histological and cytopathological cancer specimens].
Denoux Y, Blanc-Vincent MP, Simony-Lafontaine J, Verriele-Beurrier V, Briffod M, Voigt JJ; Fédération Nationale des Centres de Lutte contre le Cancer; Standards, Options and Recommendations; Ligue contre le Cancer 101 Comités; Fédération Hospitalières de France; FNCHRU; Fédération Française de Cancerologie. Denoux Y, et al. Ann Pathol. 2003 Jun;23(3):266-78. Ann Pathol. 2003. PMID: 12909833 Review. French.
[Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients].
Coindre JM, Blanc-Vincent MP, Collin F, Mac Grogan G, Balaton A, Voigt JJ, Arnould L, Bailly C, Brifford M, Bibeau F, Fontanière B, Ghnassia JP, Guinebretière JM, Le Doussal V, Mauriac L, Merrouche Y, Sabourin JC, Sastre-Garau X, Sigal-Zafrani B, Verriele-Beurrier V, Vielh P. Coindre JM, et al. Bull Cancer. 2001 Aug;88(8):765-73. Bull Cancer. 2001. PMID: 11578945 Free article. French.
[The RENAPE network: towards a new healthcare organization for the treatment of rare tumors of the peritoneum. Description of the network and role of the pathologists].
Villeneuve L, Isaac S, Glehen O, Capovilla M, Chevallier A, Croce S, Dartigues P, Fontaine J, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery E, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F. Villeneuve L, et al. Ann Pathol. 2014 Feb;34(1):4-8. doi: 10.1016/j.annpat.2014.01.008. Epub 2014 Feb 20. Ann Pathol. 2014. PMID: 24630631 French.
[Peritoneal malignant mesothelioma: review and recent data].
Mery É, Hommell-Fontaine J, Capovilla M, Chevallier A, Bibeau F, Croce S, Dartigues P, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Poizat F, Robin N, Valmary-Degano S, Verriele-Beurrier V, Villeneuve L, Isaac S. Mery É, et al. Ann Pathol. 2014 Feb;34(1):26-33. doi: 10.1016/j.annpat.2014.01.004. Epub 2014 Feb 11. Ann Pathol. 2014. PMID: 24630634 Review. French.
[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].
Dartigues P, Isaac S, Villeneuve L, Glehen O, Capovilla M, Chevallier A, Croce S, Kaci R, Lang-Averous G, Laverriere MH, Leroux-Broussier A, Mery É, Poizat F, Valmary-Degano S, Verriele-Beurrier V, Gilly FN, Bibeau F. Dartigues P, et al. Ann Pathol. 2014 Feb;34(1):14-25. doi: 10.1016/j.annpat.2014.01.012. Epub 2014 Feb 25. Ann Pathol. 2014. PMID: 24630633 French.
Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study.
Valmary-Degano S, Colpart P, Villeneuve L, Monnien F, M'Hamdi L, Lang Averous G, Capovilla M, Bibeau F, Laverriere MH, Verriele-Beurrier V, Ben Rejeb H, Dartigues P, Hommell-Fontaine J, Gilly FN, Isaac S, Mery E; French RENAPE Network. Valmary-Degano S, et al. Among authors: verriele beurrier v. Eur J Surg Oncol. 2017 Oct;43(10):1915-1923. doi: 10.1016/j.ejso.2017.05.009. Epub 2017 May 18. Eur J Surg Oncol. 2017. PMID: 28619621
Tertiary lymphoid structures in epithelioid malignant peritoneal mesothelioma are associated with neoadjuvant chemotherapy, but not with prognosis.
Benzerdjeb N, Dartigues P, Kepenekian V, Valmary-Degano S, Mery E, Avérous G, Chevallier A, Laverriere MH, Villa I, Harou O, Sallé FG, Villeneuve L, Glehen O, Isaac S, Hommell-Fontaine J, Bibeau F; RENAPE Network. Benzerdjeb N, et al. Virchows Arch. 2021 Oct;479(4):765-772. doi: 10.1007/s00428-021-03099-1. Epub 2021 Apr 14. Virchows Arch. 2021. PMID: 33855595
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy to Treat Pseudomyxoma Peritonei of Ovarian Origin: A Retrospective French RENAPE Group Study.
Trecourt A, Bakrin N, Glehen O, Gertych W, Villeneuve L, Isaac S, Benzerdjeb N, Fontaine J, Genestie C, Dartigues P, Leroux A, Quenet F, Marchal F, Odin C, Khellaf L, Svrcek M, Thierry S, Augros M, Omar A, Devouassoux-Shisheboran M, Kepenekian V; RENAPE Group. Trecourt A, et al. Ann Surg Oncol. 2024 May;31(5):3325-3338. doi: 10.1245/s10434-023-14850-0. Epub 2024 Feb 10. Ann Surg Oncol. 2024. PMID: 38341381 Free PMC article.
Ovarian and peritoneal psammocarcinoma: Results of a multicenter study on 25 patients.
Delhorme JB, Ohayon J, Gouy S, Averous G, Genestie C, Gaichies L, Glehen O, Guilloit JM, Pezet D, Quenet F, Ferron G, Brigand C, Morice P, Honoré C; French Network for Rare Peritoneal Malignancies (RENAPE). Delhorme JB, et al. Eur J Surg Oncol. 2020 May;46(5):862-867. doi: 10.1016/j.ejso.2019.12.005. Epub 2019 Dec 9. Eur J Surg Oncol. 2020. PMID: 31902591
19 results